Evidence map›Paper›PMID 30301860›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.

Ryan J Cornelius, Jinge Si, Catherina A Cuevas, Jonathan W Nelson, Brittany D K Gratreak, Ruggero Pardi, Chao-Ling Yang, David H Ellison

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Kidney kallikrein-1 contributes to cleavage of γ-ENaC in vivo.American journal of physiology. Renal physiology · 2026
    Article
  2. Piezo1 dictates KProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Familial Hyperkalemic Hypertension.Comprehensive Physiology · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. NovelHypertension (Dallas, Tex. : 1979) · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. The WNK signaling pathway and salt-sensitive hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding.American journal of physiology. Renal physiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ryan J CorneliusDivision of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon.
Jinge SiDivision of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon.
Catherina A CuevasDivision of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon.
Jonathan W NelsonDivision of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon.
Brittany D K GratreakDivision of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon.
Ruggero PardiSchool of Medicine and Scientific Institute, San Raffaele University, Milan, Italy; and.
Chao-Ling YangDivision of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon.
David H EllisonDivision of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon; ellisond@ohsu.edu.
Oregon Health & Science University · USSan Raffaele University of Rome · ITVA Portland Health Care System · US

Funding

WNK Kinase Regulation of Thiazide-sensitive NaCl TransportR01DK051496 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI David Hoadley Ellison, CHAO-LING YANG · 1998 to 2026
$8.4M
Nephrology Training GrantT32DK067864 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2006 to 2015
$1.2M
The Relationship Between the FHHt CUL3 Mutant and the CSN and its Effects on Substrate-Specific CUL3 Ligase FunctionF32DK112531 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI CORNELIUS, RYAN J · 2016 to 2018
$123k
Renal Effects of AldosteroneI01BX002228 · VA · PORTLAND VA MEDICAL CENTER · PI ELLISON, DAVID H · 2014 to 2021
–
BLRD VA I01 BX002228NIDDK NIH HHS F32 DK112531NIDDK NIH HHS R01 DK051496NIDDK NIH HHS T32 DK067864
6 · The paper itself

Abstract

backgroundThe familial hyperkalemic hypertension (FHHt) cullin 3 (CUL3) mutant does not degrade WNK kinases normally, thereby leading to thiazide-sensitive Na-Cl cotransporter (NCC) activation. CUL3 mutant (CUL3

methodsThe Pax8/LC1 mouse system was used to generate mice in which the catalytically active CSN subunit,

resultsWestern blot analysis demonstrated that

conclusionsTogether, the results indicate that deficient CSN binding contributes importantly to the FHHt phenotype. Although defective CUL3

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCOP9 Signalosome ComplexCullin ProteinsDisease Models, AnimalFemaleHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsKidneyMaleMiceMice, Inbred C57BLMice, KnockoutMicrofilament ProteinsMicroscopy, FluorescenceAdaptor Proteins, Signal TransducingCOP9 Signalosome ComplexCOPS5 protein, humanCops5 protein, mouseCul3 protein, mouseCullin ProteinsIntracellular Signaling Peptides and ProteinsKLHL3 protein, mouseMicrofilament ProteinsOXSR1 protein, mousePeptide HydrolasesPrkwnk4 protein, mouseProtein Serine-Threonine KinasesStk39 protein, mouseCell & Transport Physiologydistal tubuleNa transportrenal hypertension

Identifiers

PMID30301860
PMCPMC6218864
OpenAlexW2896179797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.